Please login to the form below

Not currently logged in
Email:
Password:

HR

This page shows the latest HR news and features for those working in and with pharma, biotech and healthcare.

Takeda highlights 12 NMEs with $10bn-plus sales potential at R&D day

Takeda highlights 12 NMEs with $10bn-plus sales potential at R&D day

It’s due for first regulatory verdicts in 2021. Pevonedistat (TAK-924) for HR-MDS: Pevonedistat is a selective NEDD8 activating enzyme (NAE) inhibitor being developed as a cancer treatment, initially ... for high-risk myelodysplastic syndromes (HR-MDS),

Latest news

More from news
Approximately 1 fully matching, plus 51 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 1 fully matching, plus 9 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 18 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 44 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Publicis Resolute

Publicis Resolute provides real-life practical solutions to your issues, without fuss or fluff. We are an experienced team with a...

Latest intelligence

Using human insights to push healthcare communications forward
This blog highlights the value of human perspectives, showing how insights can propel healthcare communications forward to ultimately improve lives...
RWE Blog 4: The place of real-world evidence in the market access strategy
The fourth and final blog in our latest series focuses on market access strategy. This follows our evaluation of the role of real-world data (RWD) and real-world evidence (RWE) in...
RWE Blog 3: Is real-world evidence the holy grail
We began our four-blog series by evaluating the role of real-world data (RWD) and real-world-evidence (RWE) in Real-world challenges and real-world data, and understanding the payer's perspective, in Payers use...

Infographics